Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Highlights of 584 Amendment to Claims dated 11/8

Highlights of 584 Amendment to Claims dated 11/8

posted on Dec 09, 2007 09:21AM

I forgot who provided us with the link to the uspto and the app # 9008299 (think it was EH). By the way, does anyone have the app numbers for the other re-exams?

Here are some highlights just in case you are interested.

Regarding the 584

Claims 1-29 remain in the patent

1-28 are not subject to re-exam

29 is subject to re-exam

Claims 30-54 are new claims added by the amendment

Claims 29-54 are subject to reexam

Support for 30-54 can be found in Section XII

Examiner review...Sept. 13...attended by examiner Banankhad, Charles Moore and attorney of record Larry Henneman. The objective for patent owner was to present some of the arguments and to give examiners an opportunity to ask question

Claim 29 had been rejected as being anticipated by 11 references

Patent owner submits that claim 29 is patentable over each and every one of those references.

Section XII - new claims 30-54 Patent owner submits that new claims are patentable over prior art of record for same reasons with respect to 29

Patent owner believes that all claims pending in the application are in condition for allowance

Share
New Message
Please login to post a reply